Evidence map›Paper›PMID 34618092›Full record

ArticlePlant physiology2021

Co-targeting strategy for precise, scarless gene editing with CRISPR/Cas9 and donor ssODNs in Chlamydomonas.

Soujanya Akella, Xinrong Ma, Romana Bacova, Zachary P Harmer, Martina Kolackova, Xiaoxue Wen, David A Wright, Martin H Spalding, Donald P Weeks, Heriberto Cerutti

Open access · greenAbstract read
In one paragraph

Article in Plant physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Gene Editing inBio-protocol · 2026
    Article
  3. Article
  4. Article
  5. CRISPR-Cas Technology TurnsMarine drugs · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Progress and challenges in CRISPR/Cas applications in microalgae.Journal of microbiology (Seoul, Korea) · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Increased Lipids inInternational journal of molecular sciences · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Soujanya AkellaSchool of Biological Sciences and Center for Plant Science Innovation, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, USA.ORCID 0000-0002-6178-0843
Xinrong MaSchool of Biological Sciences and Center for Plant Science Innovation, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, USA.
Romana BacovaDepartment of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00, Brno, Czech Republic.ORCID 0000-0001-6053-0503
Zachary P HarmerSchool of Biological Sciences and Center for Plant Science Innovation, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, USA.ORCID 0000-0003-3710-9336
Martina KolackovaDepartment of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00, Brno, Czech Republic.ORCID 0000-0002-2469-9587
Xiaoxue WenSchool of Biological Sciences and Center for Plant Science Innovation, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, USA.
David A WrightDepartment of Genetics, Development and Cell Biology, Iowa State University, Ames, Iowa 50011, USA.ORCID 0000-0001-5555-4949
Martin H SpaldingDepartment of Genetics, Development and Cell Biology, Iowa State University, Ames, Iowa 50011, USA.ORCID 0000-0003-1380-7519
Donald P WeeksDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, USA.
Heriberto CeruttiSchool of Biological Sciences and Center for Plant Science Innovation, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, USA.ORCID 0000-0002-3158-1368
University of Nebraska–Lincoln · USIowa State University · USMendel University in Brno · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Programmable site-specific nucleases, such as the clustered regularly interspaced short palindromic repeat (CRISPR)/ CRISPR-associated protein 9 (Cas9) ribonucleoproteins (RNPs), have allowed creation of valuable knockout mutations and targeted gene modifications in Chlamydomonas (Chlamydomonas reinhardtii). However, in walled strains, present methods for editing genes lacking a selectable phenotype involve co-transfection of RNPs and exogenous double-stranded DNA (dsDNA) encoding a selectable marker gene. Repair of the dsDNA breaks induced by the RNPs is usually accompanied by genomic insertion of exogenous dsDNA fragments, hindering the recovery of precise, scarless mutations in target genes of interest. Here, we tested whether co-targeting two genes by electroporation of pairs of CRISPR/Cas9 RNPs and single-stranded oligodeoxynucleotides (ssODNs) would facilitate the recovery of precise edits in a gene of interest (lacking a selectable phenotype) by selection for precise editing of another gene (creating a selectable marker)-in a process completely lacking exogenous dsDNA. We used PPX1 (encoding protoporphyrinogen IX oxidase) as the generated selectable marker, conferring resistance to oxyfluorfen, and identified precise edits in the homolog of bacterial ftsY or the WD and TetratriCopeptide repeats protein 1 genes in ∼1% of the oxyfluorfen resistant colonies. Analysis of the target site sequences in edited mutants suggested that ssODNs were used as templates for DNA synthesis during homology directed repair, a process prone to replicative errors. The Chlamydomonas acetolactate synthase gene could also be efficiently edited to serve as an alternative selectable marker. This transgene-free strategy may allow creation of individual strains containing precise mutations in multiple target genes, to study complex cellular processes, pathways, or structures.

Indexed as

CRISPR-Cas SystemsAlgal ProteinsChlamydomonasGene EditingRibonucleoproteinsAlgal ProteinsRibonucleoproteins

Identifiers

PMID34618092
PMCPMC8644747
OpenAlexW3197976482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.